Login

Ben McMillan, founder and CIO of IDX Digital Assets, analyzes the future of crypto markets following recent downturns. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

01:10:00
 5E’s advanced materials business is underpinned by its low cost, light environmental touch boron resource in Southern California, which is designated Critical Infrastructure by the U.S.|J.T Starzecki,CMO, 5E Advanced Materials, Inc
00:10:00
Fresh Perspectives: Jonathan Ruffer on Investment, Philanthropy, and Cultural Heritage
00:10:00
A Quantitative Edge in China A-Shares and Global Access via Hong Kong|Bo Huang,President,Jasper Capital
00:10:00
Advice and Insights from a Veteran CEO at a 95-Year-Old Company
00:10:00
The Power of Guidance: How a Trusted Financial Coach Can Help You Navigate and Achieve Your Financial Goals with Dimensional Fund Advisors
00:10:00
Il Capitale Naturale: Preservazione e Rigenerazione con Lombard Odier Investment Managers
00:10:00
China's Economic Response to COVID-19 and Metal Supply-Demand Outlook
00:10:00
Exploration and Development Opportunities at Tyranno Resources
00:10:00
Image Resources: Advancing Mineral Sands Projects from Exploration to Production
00:10:00
Oswald Mosley: British Fascism and the Black Shirts Era|Stephen Dorril,Professor,Huddersfield University
00:10:00
John Elkann on Family Ownership, Leading Exor, and the Legacy of Ferrari and Juventus with Nicolai Tangen
00:10:00
Common Pitfalls for Founder led Sales|

© 2017 - Neuhu+